microbe.net
Merck: Phase 3 Studies of Bezlotoxumab to Prevent Clostridium Difficile Infection Recurrence
Bezlotoxumab is not an antibiotic. It is a selective, fully-human, monoclonal antibody designed to neutralize C. difficile toxin B, a toxin that can damage the gut wall and cause inflammatio…